Cite

Allison, L., & Moncrieff, J. (2014). ‘Rapid tranquillisation’: an historical perspective on its emergence in the context of the development of antipsychotic medications. History of psychiatry, 25(1), 57–69.AllisonL.MoncrieffJ.2014‘Rapid tranquillisation’: an historical perspective on its emergence in the context of the development of antipsychotic medicationsHistory of psychiatry251576910.1177/0957154X1351257324594821Search in Google Scholar

Artigas-Pallarés, J. (2006). Pharmacological treatment of mental retardation. Revista de Neurologia, 42(S1): S109–S115.Artigas-PallarésJ.2006Pharmacological treatment of mental retardationRevista de Neurologia42S1S109S11510.33588/rn.42S01.2005702Search in Google Scholar

Bellino, S., Rinaldi, C., Bozzatello, P., & Bogetto, F. (2011). Pharmacotherapy of borderline personality disorder: A systematic review. Current medicinal chemistry, 18(22), 3322–3329.BellinoS.RinaldiC.BozzatelloP.BogettoF.2011Pharmacotherapy of borderline personality disorder: A systematic reviewCurrent medicinal chemistry18223322332910.2174/09298671179650468221728970Search in Google Scholar

Bhana, A., Mntambo, N., Gigaba, S. G., Luvuno, Z. P. B., Grant, M., Ackerman, D., ... & Petersen, I. (2019). Validation of a brief mental health screening tool for common mental disorders in primary healthcare. SAMJ: South African Medical Journal, 109(4), 278–283.BhanaA.MntamboN.GigabaS. G.LuvunoZ. P. B.GrantM.AckermanD.PetersenI.2019Validation of a brief mental health screening tool for common mental disorders in primary healthcareSAMJ: South African Medical Journal109427828310.7196/SAMJ.2019.v109i4.13664702917031084695Search in Google Scholar

Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019). Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. Neuroscience & Biobehavioral Reviews [Epub ahead of print].CannellaN.UbaldiM.MasiA.BramucciM.RobertoM.BifoneA.CiccocioppoR.2019Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter futureNeuroscience & Biobehavioral Reviews[Epub ahead of print].10.1016/j.neubiorev.2019.05.014669221831112713Search in Google Scholar

Castaldelli-Maia, J. M., Andrade, L. H., Keyes, K. M., Cerdá, M., Pilowsky, D. J., & Martins, S. S. (2016). Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users. Journal of psychiatric research, 80, 79–86.Castaldelli-MaiaJ. M.AndradeL. H.KeyesK. M.CerdáM.PilowskyD. J.MartinsS. S.2016Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid usersJournal of psychiatric research80798610.1016/j.jpsychires.2016.05.007498016027302873Search in Google Scholar

Castaldelli-Maia, J. M., Andrade, L. H., Storr, C. L., Viana, M. C., Andrade, A. G., & Martins, S. S. (2018a). The latent trait of ICD-11 nicotine dependence criteria: Dimensional and categorical phenotypes. Psychiatry research, 266, 275–283.Castaldelli-MaiaJ. M.AndradeL. H.StorrC. L.VianaM. C.AndradeA. G.MartinsS. S.2018aThe latent trait of ICD-11 nicotine dependence criteria: Dimensional and categorical phenotypesPsychiatry research26627528310.1016/j.psychres.2018.03.01829605101Search in Google Scholar

Castaldelli-Maia, J. M., Martins, S. S., & Walker, N. (2018b). The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation. The International journal on drug policy, 58, 121–125.Castaldelli-MaiaJ. M.MartinsS. S.WalkerN.2018bThe effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian FederationThe International journal on drug policy5812112510.1016/j.drugpo.2018.05.01229929154Search in Google Scholar

Castaldelli-Maia, J. M., Wang, Y. P., Borges, G., Silveira, C. M., Siu, E. R., Viana, M. C., ... & Andrade, L. H. (2015). Investigating dimensionality and measurement bias of DSM-5 alcohol use disorder in a representative sample of the largest metropolitan area in South America. Drug and alcohol dependence, 152, 123–130.Castaldelli-MaiaJ. M.WangY. P.BorgesG.SilveiraC. M.SiuE. R.VianaM. C.AndradeL. H.2015Investigating dimensionality and measurement bias of DSM-5 alcohol use disorder in a representative sample of the largest metropolitan area in South AmericaDrug and alcohol dependence15212313010.1016/j.drugalcdep.2015.04.024484001826002376Search in Google Scholar

Citrome, L. (2016). Emerging pharmacological therapies in schizophrenia: what’s new, what’s different, what’s next?. CNS spectrums, 21(S1), 1–12.CitromeL.2016Emerging pharmacological therapies in schizophrenia: what’s new, what’s different, what’s next?CNS spectrums21S111210.1017/S109285291600072928044942Search in Google Scholar

Cook Jr, E. H., Rowlett, R., Jaselskis, C., & Leventhal, B. L. (1992). Fluoxetine treatment of children and adults with autistic disorder and mental retardation. Journal of the American Academy of Child & Adolescent Psychiatry, 31(4), 739–745.CookE. H.JrRowlettR.JaselskisC.LeventhalB. L.1992Fluoxetine treatment of children and adults with autistic disorder and mental retardationJournal of the American Academy of Child & Adolescent Psychiatry31473974510.1097/00004583-199207000-000241644739Search in Google Scholar

Corrigan, P. W., Watson, A. C., Heyrman, M. L., Warpinski, A., Gracia, G., Slopen, N., & Hall, L. L. (2005). Structural stigma in state legislation. Psychiatric Services, 56(5), 557–563.CorriganP. W.WatsonA. C.HeyrmanM. L.WarpinskiA.GraciaG.SlopenN.HallL. L.2005Structural stigma in state legislationPsychiatric Services56555756310.1176/appi.ps.56.5.55715872164Search in Google Scholar

Degenhardt, L., Bharat, C., Bruno, R., Glantz, M. D., Sampson, N. A., Lago, L., ... & Caldas-de-Almeida, J. M. (2019). Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO’s World Mental Health Surveys. Addiction, 114(3), 534–552.DegenhardtL.BharatC.BrunoR.GlantzM. D.SampsonN. A.LagoL.Caldas-de-AlmeidaJ. M.2019Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD-11 and other classification systems: analysis of data from the WHO’s World Mental Health SurveysAddiction114353455210.1111/add.14482705995830370636Search in Google Scholar

DeLuca, J. S., & Clement, T. (2017). Does individual stigma predict mental health funding attitudes? Toward an understanding of resource allocation and social climate. The Israel journal of psychiatry and related sciences, 54(1), 6–17.DeLucaJ. S.ClementT.2017Does individual stigma predict mental health funding attitudes? Toward an understanding of resource allocation and social climateThe Israel journal of psychiatry and related sciences541617Search in Google Scholar

Estrada-Orozco, K., Bonilla-Vargas, K., Cruz, F., Mancera, O., Ruiz, M., Alvarez, L., ... & Arboleda, H. (2018). Cognitive assessment test: validation of a short cognitive test for the detection of mild cognitive disorder. International Journal of Alzheimer’s Disease, 2018, 3280621.Estrada-OrozcoK.Bonilla-VargasK.CruzF.ManceraO.RuizM.AlvarezL.ArboledaH.2018Cognitive assessment test: validation of a short cognitive test for the detection of mild cognitive disorderInternational Journal of Alzheimer’s Disease20183280621.10.1155/2018/3280621605107930057805Search in Google Scholar

Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008). Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. The FASEB journal, 22(2), 338–342.FalagasM. E.PitsouniE. I.MalietzisG. A.PappasG.2008Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknessesThe FASEB journal22233834210.1096/fj.07-9492LSF17884971Search in Google Scholar

Fowler, B. M. (2019). Clinical Education to Decrease Perceived Barriers to Delirium Screening in Adult Intensive Care Units. Critical care nursing quarterly, 42(1), 41–43.FowlerB. M.2019Clinical Education to Decrease Perceived Barriers to Delirium Screening in Adult Intensive Care UnitsCritical care nursing quarterly421414310.1097/CNQ.000000000000023530507662Search in Google Scholar

Frandsen, T. F., Eriksen, M. B., Hammer, D. M. G., & Christensen, J. B. (2019). PubMed coverage varied across specialties and over time: a large-scale study of included studies in Cochrane reviews. Journal of clinical epidemiology, 112, 59–66.FrandsenT. F.EriksenM. B.HammerD. M. G.ChristensenJ. B.2019PubMed coverage varied across specialties and over time: a large-scale study of included studies in Cochrane reviewsJournal of clinical epidemiology112596610.1016/j.jclinepi.2019.04.01531051247Search in Google Scholar

Franklin, J. M., & Schneeweiss, S. (2017). When and how can real world data analyses substitute for randomized controlled trials?. Clinical Pharmacology & Therapeutics, 102(6), 924–933.FranklinJ. M.SchneeweissS.2017When and how can real world data analyses substitute for randomized controlled trials?Clinical Pharmacology & Therapeutics102692493310.1002/cpt.85728836267Search in Google Scholar

Gamache, D., Savard, C., Lemelin, S., Côté, A., & Villeneuve, É. (2018). Premature Termination of Psychotherapy in Patients With Borderline Personality Disorder: A Cluster-Analytic Study. The Journal of nervous and mental disease, 206(4), 231–238.GamacheD.SavardC.LemelinS.CôtéA.VilleneuveÉ.2018Premature Termination of Psychotherapy in Patients With Borderline Personality Disorder: A Cluster-Analytic StudyThe Journal of nervous and mental disease206423123810.1097/NMD.000000000000076429252927Search in Google Scholar

Grossman, J., & Mackenzie, F. J. (2005). The randomized controlled trial: gold standard, or merely standard?. Perspectives in biology and medicine, 48(4), 516–534.GrossmanJ.MackenzieF. J.2005The randomized controlled trial: gold standard, or merely standard?Perspectives in biology and medicine48451653410.1353/pbm.2005.009216227664Search in Google Scholar

Halladay, C. W., Trikalinos, T. A., Schmid, I. T., Schmid, C. H., & Dahabreh, I. J. (2015). Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventions. Journal of clinical epidemiology, 68(9), 1076–1084.HalladayC. W.TrikalinosT. A.SchmidI. T.SchmidC. H.DahabrehI. J.2015Using data sources beyond PubMed has a modest impact on the results of systematic reviews of therapeutic interventionsJournal of clinical epidemiology6891076108410.1016/j.jclinepi.2014.12.01726279401Search in Google Scholar

Harris, M., Chandran, S., Chakraborty, N., & Healy, D. (2005). The impact of mood stabilizers on bipolar disorder: the 1890s and 1990s compared. History of Psychiatry, 16(4), 423–434.HarrisM.ChandranS.ChakrabortyN.HealyD.2005The impact of mood stabilizers on bipolar disorder: the 1890s and 1990s comparedHistory of Psychiatry16442343410.1177/0957154X0505208816450486Search in Google Scholar

Hasan, A., Bandelow, B., Yatham, L. N., Berk, M., Falkai, P., Möller, H. J., ... & WFSBP Guideline Task Force Chairs. (2019). WFSBP guidelines on how to grade treatment evidence for clinical guideline development. The World Journal of Biological Psychiatry, 20(1), 2–16.HasanA.BandelowB.YathamL. N.BerkM.FalkaiP.MöllerH. J.WFSBP Guideline Task Force Chairs2019WFSBP guidelines on how to grade treatment evidence for clinical guideline developmentThe World Journal of Biological Psychiatry20121610.1080/15622975.2018.155734630526182Search in Google Scholar

Hemayattalab, R., & Movahedi, A. (2010). Effects of different variations of mental and physical practice on sport skill learning in adolescents with mental retardation. Research in developmental disabilities, 31(1), 81–86.HemayattalabR.MovahediA.2010Effects of different variations of mental and physical practice on sport skill learning in adolescents with mental retardationResearch in developmental disabilities311818610.1016/j.ridd.2009.07.02219875270Search in Google Scholar

Hockenberry, J. M., Joski, P., Yarbrough, C., & Druss, B. G. (2019). Trends in treatment and spending for patients receiving outpatient treatment of depression in the United States, 1998–2015. JAMA psychiatry, 76(8), 810–817.HockenberryJ. M.JoskiP.YarbroughC.DrussB. G.2019Trends in treatment and spending for patients receiving outpatient treatment of depression in the United States, 1998–2015JAMA psychiatry76881081710.1001/jamapsychiatry.2019.0633648790031017627Search in Google Scholar

Holzapfel, E. M., & Szabo, C. P. (2018). Pharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient population. Global Psychiatry, 1(2), 39–51.HolzapfelE. M.SzaboC. P.2018Pharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient populationGlobal Psychiatry12395110.2478/gp-2018-0006Search in Google Scholar

Hoogendam, A., de Vries Robbe, P. F., Stalenhoef, A. F., & Overbeke, A. J. P. (2009). Evaluation of PubMed filters used for evidence-based searching: validation using relative recall. Journal of the Medical Library Association: JMLA, 97(3), 186.HoogendamA.de Vries RobbeP. F.StalenhoefA. F.OverbekeA. J. P.2009Evaluation of PubMed filters used for evidence-based searching: validation using relative recallJournal of the Medical Library Association: JMLA97318610.3163/1536-5050.97.3.007270644619626144Search in Google Scholar

Huang, Y. J., Lane, H. Y., & Lin, C. H. (2017). New treatment strategies of depression: based on mechanisms related to neuroplasticity. Neural plasticity, 2017, 4605971.HuangY. J.LaneH. Y.LinC. H.2017New treatment strategies of depression: based on mechanisms related to neuroplasticityNeural plasticity20174605971.10.1155/2017/4605971540558728491480Search in Google Scholar

Koelkebeck, K., Stefanovic, M. P., Frydecka, D., Palumbo, C., Andlauer, O., Riese, F., ... & da Costa, M. P. (2019). Barriers and facilitators to conducting research by early career psychiatrists: a literature review. Global Psychiatry, 2(2), 135–153.KoelkebeckK.StefanovicM. P.FrydeckaD.PalumboC.AndlauerO.RieseF.da CostaM. P.2019Barriers and facilitators to conducting research by early career psychiatrists: a literature reviewGlobal Psychiatry2213515310.2478/gp-2019-0018Search in Google Scholar

Koskinen, J., Isohanni, M., Paajala, H., Jääskeläinen, E., Nieminen, P., Koponen, H., ... & Miettunen, J. (2008). How to use bibliometric methods in evaluation of scientific research? An example from Finnish schizophrenia research. Nordic journal of psychiatry, 62(2), 136–143.KoskinenJ.IsohanniM.PaajalaH.JääskeläinenE.NieminenP.KoponenH.MiettunenJ.2008How to use bibliometric methods in evaluation of scientific research? An example from Finnish schizophrenia researchNordic journal of psychiatry62213614310.1080/0803948080196166718569777Search in Google Scholar

Kupfersmid, J. (2019). Freud’s Clinical Theories Then and Now. Psychodynamic psychiatry, 47(1), 81–97.KupfersmidJ.2019Freud’s Clinical Theories Then and NowPsychodynamic psychiatry471819710.1521/pdps.2019.47.1.8130840557Search in Google Scholar

Lauber, C., Ajdacic-Gross, V., Fritschi, N., Stulz, N., & Rössler, W. (2005). Mental health literacy in an educational elite – an online survey among university students. BMC Public Health, 5(1), 44.LauberC.Ajdacic-GrossV.FritschiN.StulzN.RösslerW.2005Mental health literacy in an educational elite – an online survey among university studentsBMC Public Health514410.1186/1471-2458-5-44Search in Google Scholar

Little, J. D., McFarlane, J., & Ducharme, H. M. (2002). ECT use delayed in the presence of comorbid mental retardation: a review of clinical and ethical issues. The journal of ECT, 18(4), 218–222.LittleJ. D.McFarlaneJ.DucharmeH. M.2002ECT use delayed in the presence of comorbid mental retardation: a review of clinical and ethical issuesThe journal of ECT18421822210.1097/00124509-200212000-00010Search in Google Scholar

Liu, B., Liu, J., Wang, M., Zhang, Y., & Li, L. (2017). From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Frontiers in cellular neuroscience, 11, 305.LiuB.LiuJ.WangM.ZhangY.LiL.2017From serotonin to neuroplasticity: evolvement of theories for major depressive disorderFrontiers in cellular neuroscience1130510.3389/fncel.2017.00305Search in Google Scholar

López-Muñoz, F., Tracy, D. K., Povedano-Montero, F. J., Breedvelt, J., García-Pacios, J., Fernández-Martín, M. P., ... & Álamo, C. (2019). Trends in the scientific literature on atypical antipsychotic drugs in the United Kingdom: a bibliometric study. Therapeutic advances in psychopharmacology, 9, 2045125318820207.López-MuñozF.TracyD. K.Povedano-MonteroF. J.BreedveltJ.García-PaciosJ.Fernández-MartínM. P.ÁlamoC.2019Trends in the scientific literature on atypical antipsychotic drugs in the United Kingdom: a bibliometric studyTherapeutic advances in psychopharmacology92045125318820207.10.1177/2045125318820207Search in Google Scholar

Machmutow, K., Meister, R., Jansen, A., Kriston, L., Watzke, B., Härter, M. C., & Liebherz, S. (2019). Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults. Cochrane Database of Systematic Reviews, (5), CD012855.MachmutowK.MeisterR.JansenA.KristonL.WatzkeB.HärterM. C.LiebherzS.2019Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adultsCochrane Database of Systematic Reviews5CD012855.10.1002/14651858.CD012855.pub2Search in Google Scholar

Manca, A., Cugusi, L., Dvir, Z., & Deriu, F. (2017). PubMed should raise the bar for journal inclusion. The Lancet, 390(10096), 734–735.MancaA.CugusiL.DvirZ.DeriuF.2017PubMed should raise the bar for journal inclusionThe Lancet3901009673473510.1016/S0140-6736(17)31943-8Search in Google Scholar

McNamara, C., Engelhardt, N., Potter, W., Yavorsky, C., Masotti, M., & Di Clemente, G. (2019). Risk-Based Data Monitoring: Quality Control in Central Nervous System (CNS) Clinical Trials. Therapeutic innovation & regulatory science, 53(2), 176–182.McNamaraC.EngelhardtN.PotterW.YavorskyC.MasottiM.Di ClementeG.2019Risk-Based Data Monitoring: Quality Control in Central Nervous System (CNS) Clinical TrialsTherapeutic innovation & regulatory science53217618210.1177/216847901877432529758992Search in Google Scholar

Möller-Leimkühler, A. M., Möller, H. J., Maier, W., Gaebel, W., & Falkai, P. (2016). EPA guidance on improving the image of psychiatry. European archives of psychiatry and clinical neuroscience, 266(2), 139–154.Möller-LeimkühlerA. M.MöllerH. J.MaierW.GaebelW.FalkaiP.2016EPA guidance on improving the image of psychiatryEuropean archives of psychiatry and clinical neuroscience266213915410.1007/s00406-016-0678-526874959Search in Google Scholar

Newton-Howes, G., Tyrer, P., Johnson, T., Mulder, R., Kool, S., Dekker, J., & Schoevers, R. (2014). Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis. Journal of Personality Disorders, 28(4), 577–593.Newton-HowesG.TyrerP.JohnsonT.MulderR.KoolS.DekkerJ.SchoeversR.2014Influence of personality on the outcome of treatment in depression: systematic review and meta-analysisJournal of Personality Disorders28457759310.1521/pedi_2013_27_07024256103Search in Google Scholar

Overholser, J. C. (2002). Treatments for depression: wisdom imparted from treatments discarded. The International Journal of Psychiatry in Medicine, 32(4), 317–336.OverholserJ. C.2002Treatments for depression: wisdom imparted from treatments discardedThe International Journal of Psychiatry in Medicine32431733610.2190/89HB-8GXD-06XC-5BQK12779182Search in Google Scholar

Reed, G. M. (2010). Toward ICD-11: Improving the clinical utility of WHO’s International Classification of mental disorders. Professional Psychology: Research and Practice, 41(6), 457.ReedG. M.2010Toward ICD-11: Improving the clinical utility of WHO’s International Classification of mental disordersProfessional Psychology: Research and Practice41645710.1037/a0021701Search in Google Scholar

Reed, G. M. (2018). Progress in developing a classification of personality disorders for ICD-11. World Psychiatry, 17(2), 227–229.ReedG. M.2018Progress in developing a classification of personality disorders for ICD-11World Psychiatry17222722910.1002/wps.20533598053129856549Search in Google Scholar

Ross, C. A. (2005). A proposed trial of dialectical behavior therapy and trauma model therapy. Psychological reports, 96(S3), 901–911.RossC. A.2005A proposed trial of dialectical behavior therapy and trauma model therapyPsychological reports96S390191110.2466/pr0.96.3c.901-91116173357Search in Google Scholar

Sedler, M. J. (2016). Medicalization in psychiatry: the medical model, descriptive diagnosis, and lost knowledge. Medicine, Health Care and Philosophy, 19(2), 247–252.SedlerM. J.2016Medicalization in psychiatry: the medical model, descriptive diagnosis, and lost knowledgeMedicine, Health Care and Philosophy19224725210.1007/s11019-015-9670-526602907Search in Google Scholar

Shankman, S. A., Funkhouser, C. J., Klein, D. N., Davila, J., Lerner, D., & Hee, D. (2018). Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID). International journal of methods in psychiatric research, 27(1), e1590.ShankmanS. A.FunkhouserC. J.KleinD. N.DavilaJ.LernerD.HeeD.2018Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM-5 (SCID)International journal of methods in psychiatric research271e159010.1002/mpr.1590583436229034525Search in Google Scholar

Simeon, D., & Knutelska, M. (2005). An open trial of naltrexone in the treatment of depersonalization disorder. Journal of clinical Psychopharmacology, 25(3), 267–270.SimeonD.KnutelskaM.2005An open trial of naltrexone in the treatment of depersonalization disorderJournal of clinical Psychopharmacology25326727010.1097/01.jcp.0000162803.61700.4f15876908Search in Google Scholar

Skodol, A. E., Geier, T., Grant, B. F., & Hasin, D. S. (2014). Personality disorders and the persistence of anxiety disorders in a nationally representative sample. Depression and Anxiety, 31(9), 721–728.SkodolA. E.GeierT.GrantB. F.HasinD. S.2014Personality disorders and the persistence of anxiety disorders in a nationally representative sampleDepression and Anxiety31972172810.1002/da.2228724995387Search in Google Scholar

Stuhec, M., & Gorenc, K. (2019). Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort study. Global Psychiatry, 2(2), 155–163.StuhecM.GorencK.2019Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort studyGlobal Psychiatry2215516310.2478/gp-2019-0013Search in Google Scholar

Stuhec, M., Munda, B., Svab, V., & Locatelli, I. (2015). Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. Journal of affective disorders, 178, 149–159.StuhecM.MundaB.SvabV.LocatelliI.2015Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropionJournal of affective disorders17814915910.1016/j.jad.2015.03.00625813457Search in Google Scholar

Thoma, N., Pilecki, B., & McKay, D. (2015). Contemporary cognitive behavior therapy: A review of theory, history, and evidence. Psychodynamic Psychiatry, 43(3), 423–461.ThomaN.PileckiB.McKayD.2015Contemporary cognitive behavior therapy: A review of theory, history, and evidencePsychodynamic Psychiatry43342346110.1521/pdps.2015.43.3.42326301761Search in Google Scholar

Tyrer, P. (2009). Why borderline personality disorder is neither borderline nor a personality disorder. Personality and Mental Health, 3(2), 86–95.TyrerP.2009Why borderline personality disorder is neither borderline nor a personality disorderPersonality and Mental Health32869510.1002/pmh.78Search in Google Scholar

Vogel, R. J. (2002). Pharmaceutical patents and price controls. Clinical therapeutics, 24(7), 1204–1222.VogelR. J.2002Pharmaceutical patents and price controlsClinical therapeutics2471204122210.1016/S0149-2918(02)80031-5Search in Google Scholar

Wang, J., Chen, Z., Sun, W., Zheng, Y., Hui, L., Liu, X., ... & Zhang, T. (2019). A Strategy to Address High Comorbidity of Personality Disorders in a Chinese Population: A Principal and Subordinate Diagnostic Model. Psychiatry, 82(3), 272–282.WangJ.ChenZ.SunW.ZhengY.HuiL.LiuX.ZhangT.2019A Strategy to Address High Comorbidity of Personality Disorders in a Chinese Population: A Principal and Subordinate Diagnostic ModelPsychiatry82327228210.1080/00332747.2019.160021831017559Search in Google Scholar

World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines (Vol. 1). World Health Organization.World Health Organization1992The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines1World Health OrganizationSearch in Google Scholar

World Health Organization. (1993). The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research (Vol. 2). World Health Organization.World Health Organization1993The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research2World Health OrganizationSearch in Google Scholar

World Health Organization. (1996). Diagnostic and management guidelines for mental disorders in primary care: ICD-10. Chapter 5, Primary care version. World Health Organization.World Health Organization1996Diagnostic and management guidelines for mental disorders in primary care: ICD-10. Chapter 5, Primary care versionWorld Health OrganizationSearch in Google Scholar